EGFR(vIII): An Oncogene with Ambiguous Role

Epidermal growth factor receptor variant III (EGFR(vIII)) seems to constitute the perfect therapeutic target for glioblastoma (GB), as it is specifically present on up to 28–30% of GB cells. In case of other tumor types, expression and possible role of this oncogene still remain controversial. In sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowska, Adrianna, Stoczyńska-Fidelus, Ewelina, Janik, Karolina, Włodarczyk, Aneta, Rieske, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024087/
https://www.ncbi.nlm.nih.gov/pubmed/32089685
http://dx.doi.org/10.1155/2019/1092587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024087/
https://www.ncbi.nlm.nih.gov/pubmed/32089685
http://dx.doi.org/10.1155/2019/1092587

Ejemplares similares